What is MBX Biosciences, Inc.'s EBIT?

MBX Biosciences, Inc. (MBX) reported EBIT of -$27.27M in Q1 2026.

How has MBX Biosciences, Inc.'s EBIT changed year-over-year?

MBX Biosciences, Inc.'s EBIT decreased by 2.8% year-over-year, from -$26.53M to -$27.27M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

MBX Biosciences, Inc. MBX EBIT

EBIT at other companies

Viking TherapeuticsVKTX

-$164.13M-196%

Amylyx Pharmaceuticals, Inc.AMLX

-$43.78M-15.8%

Nurix Therapeutics, Inc.NRIX

-$92.5M-47.1%

Eli LillyLLY

——

AmgenAMGN

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

−$27.3Moperating income=-$27.27M

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s EBIT?: MBX Biosciences, Inc. (MBX) reported EBIT of -$27.27M in Q1 2026.
How has MBX Biosciences, Inc.'s EBIT changed year-over-year?: MBX Biosciences, Inc.'s EBIT decreased by 2.8% year-over-year, from -$26.53M to -$27.27M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.